A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
Restrictions on how you're able to buy paracetamol come into effect this weekend, and are aimed at reducing related overdoses ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation in pain relief in more than two decades.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...